Vaccinex, Inc. (VCNX) Shareholders’ equity 2017–2024
Vaccinex, Inc. (VCNX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$2.5MFY2024 · since FY2017: -$125.5M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.5M | -7.7% |
| FY2023 | -$2.3M | -144.5% |
| FY2022 | $5.2M | -29.9% |
| FY2021 | $7.4M | +127.9% |
| FY2020 | -$26.6M | -1.3% |
| FY2019 | -$26.2M | -204.3% |
| FY2018 | -$8.6M | +93.1% |
| FY2017 | -$125.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice